Harbor Health Care ETF Rating → Warren Buffett's 'mystery stock' (From Stansberry Research) (Ad) Free MEDI Stock Alerts $25.19 -0.14 (-0.55%) (As of 05/21/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Harbor Health Care ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDI Aggregate RatingModerate Buy2.79Holdings in MEDI have an aggregate rating of Moderate Buy based on 386 analyst ratings issued in the past year covering 34 companies (95.6% of the portfolio).MEDI Aggregate Price Target$32.8630.42% UpsideHigh Prediction$41.02Average Prediction$32.86Low Prediction$25.12Holdings in MEDI have an aggregate price target of $32.86 and a range of $25.12 to $41.02 covering 34 companies (95.6% of the portfolio).MEDI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Harbor Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 34 MEDI Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.08%ASNDAscendis Pharma A/S$122.85+1.5%1 of 5 stars2.88$176.88 44.0%810.40%ABBVAbbVie$162.95-1.0%5 of 5 stars2.79$176.14 8.1%146.46%UNHUnitedHealth Group$523.55+1.2%5 of 5 stars2.83$570.05 8.9%18Analyst Revision6.33%LEGNLegend Biotech$42.96-5.4%3 of 5 stars2.92$82.74 92.6%124.77%LLYEli Lilly and Company$803.97+2.7%5 of 5 stars2.84$769.53 -4.3%19Analyst Revision4.51%DXCMDexCom$130.84+0.1%5 of 5 stars2.93$141.67 8.3%14Positive News4.24%PFEPfizer$28.56+0.1%5 of 5 stars2.40$35.86 25.6%153.55%OPCHOption Care Health$29.13+0.2%5 of 5 stars3.00$40.00 37.3%3Positive News3.09%LNTHLantheus$80.70-2.6%4 of 5 stars2.86$99.17 22.9%73.03%SNYSanofi$48.95+1.1%3 of 5 stars2.40$55.00 12.4%5Analyst Revision2.72%MASIMasimo$124.52-1.7%5 of 5 stars2.43$138.71 11.4%72.39%ICLRICON Public$317.88-0.3%4 of 5 stars3.00$339.44 6.8%8News Coverage2.18%RCKTRocket Pharmaceuticals$22.33-2.2%5 of 5 stars2.89$52.13 133.4%9Insider Selling2.10%COOCooper Companies$96.76-0.5%4 of 5 stars2.80$109.69 13.4%102.09%PCVXVaxcyte$73.65-3.0%0 of 5 stars3.00$78.50 6.6%41.81%INSPInspire Medical Systems$152.42-1.8%5 of 5 stars2.69$256.53 68.3%16Positive News1.67%AVTRAvantor$24.91-0.1%4 of 5 stars2.75$26.71 7.3%16Analyst RevisionPositive News1.67%GEHCGE HealthCare Technologies$81.94+0.2%4 of 5 stars2.60$94.80 15.7%10Positive News1.55%VRTXVertex Pharmaceuticals$442.00-0.9%4 of 5 stars2.48$432.18 -2.2%25Analyst UpgradePositive News1.52%ELVElevance Health$546.01+0.8%4 of 5 stars2.92$587.42 7.6%13Analyst UpgradePositive News1.48%IDXXIDEXX Laboratories$518.44-2.2%4 of 5 stars2.67$580.38 11.9%9Insider Selling1.29%IRTCiRhythm Technologies$91.50-1.2%1 of 5 stars3.00$134.00 46.4%71.25%PODDInsulet$182.79-0.7%5 of 5 stars2.82$239.44 31.0%171.23%HAEHaemonetics$93.20-2.2%4 of 5 stars2.50$108.67 16.6%41.19%MLTXMoonLake Immunotherapeutics$39.03+1.0%3 of 5 stars2.75$74.46 90.8%121.15%ALGNAlign Technology$264.02-1.3%5 of 5 stars2.50$353.00 33.7%10Positive News1.11%NBIXNeurocrine Biosciences$140.55-0.8%5 of 5 stars2.79$148.96 6.0%24Insider Selling1.10%BCYCBicycle Therapeutics$21.60-0.5%2 of 5 stars2.86$46.86 116.9%70.76%CYTKCytokinetics$60.14-0.8%4 of 5 stars2.87$81.60 35.7%150.72%RGENRepligen$166.90-2.8%4 of 5 stars2.89$197.75 18.5%9Positive News0.66%VKTXViking Therapeutics$64.23-4.9%4 of 5 stars3.10$112.38 75.0%100.60%CORCencora$217.10-1.8%4 of 5 stars2.70$233.90 7.7%100.51%XENEXenon Pharmaceuticals$38.98-3.6%3 of 5 stars3.00$59.11 51.6%9Positive News0.43%ALKSAlkermes$24.34-0.2%5 of 5 stars2.50$35.38 45.3%10Positive News This page (NYSEARCA:MEDI) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyWarren Buffett's "mystery stock"Stansberry ResearchNew Options need New Trading StrategiesNetpicksThis military-backed stock “owns” AI marketPorter & CompanyTrump’s second term “playbook” leaked?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harbor Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
